PrivateAerpio Pharmaceuticals, Inc. Kevin G. Peters bought Aerpio Pharmaceuticals, Inc. shares — SEC Form 4BUY

Kevin G. Peters, Chief Scientific Officer (NONE), bought 3,642 shares at $5.00 ($18K) on 2017-03-15, disclosed to the SEC on 2017-03-17.

SEC EDGAR Filing

0000899243-17-008160

View on SEC EDGAR

Trade context

Open-market purchase of $18k NONE by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).

First-Time BuyerOpportunistic Buy